FDA Approves Three Additional COVID-19 Vaccines, According to News Report

A news report says the Food and Drug Administration approved COVID-19 vaccine products from Pfizer, Moderna and Sanofi on Aug. 27.

By The Apex Times Newsroom2 min readAI-assisted Apex article

The Food and Drug Administration approved three additional COVID-19 vaccine products from Pfizer, Moderna and Sanofi, according to a report published Aug. 28 that pointed to an FDA approval dated Aug. 27. The report said the approvals cover three new vaccine offerings, with Pfizer and Moderna using an mRNA platform.

The Aug. 27 approval described in the report comes after a continuing cycle of FDA action on COVID-19 vaccine formulations and authorizations. The report did not, in the information provided to this desk, specify the exact commercial names of the products, the target strains or formulation details, or whether the approvals were limited by age group or dosing schedule.

The report also said that the vaccines were “authored” by Zachary Stieber via The Epoch Times, and it included a Getty Images photograph of a nurse preparing to vaccinate a child in Denver, Colo., on Nov. 3, 2021. The inclusion of that image indicates the report was written in a broader context of COVID-19 vaccination efforts, but the vaccination still referenced in the image is not evidence of the dates or content of the Aug. 27 FDA actions.

While the report’s description characterizes Pfizer and Moderna vaccines as using the messenger RNA (mRNA) platform, it does not provide the underlying regulatory pathway or the specific FDA documents that correspond to each product. It also does not list package inserts, manufacturer protocols, or the clinical endpoints cited by the agency in support of the approvals.

The practical effect of FDA vaccine approvals, regardless of formulation, is that they determine which products can be distributed and administered under FDA oversight. For providers and payers, the FDA’s action typically affects procurement decisions, inventory planning, and how vaccination programs coordinate schedules with eligibility requirements.

The next step, given the lack of direct FDA document details in the information provided here, is for readers to confirm the precise FDA approval statements, including product names, dosage or presentation, and any labeled age or risk-group restrictions through the FDA’s own release or approval documentation for the Aug. 27 approvals referenced by the report.

Why It Matters

FDA approval governs whether specific vaccine products can be distributed and administered under FDA oversight.
Product labeling and approval scope, such as age group or formulation details, can affect clinical use and procurement for providers.
The timing of FDA actions can influence vaccination program scheduling and inventory decisions.
Because the central claims are reported without direct FDA documentation in the materials provided here, verification of the exact FDA approval records is a necessary next step.

Sources

Zero Hedge: FDA Approves 3 New COVID-19 Vaccines

Key Facts

A report says the FDA approved three COVID-19 vaccine products from Pfizer, Moderna and Sanofi on Aug. 27.
The report said Pfizer and Moderna use an mRNA platform.
The report was published Aug. 28 and included a 2021 Denver vaccination photo.
The report attributed authorship to Zachary Stieber via The Epoch Times.
The information provided here does not include direct FDA approval documents or product-specific labeling details.